Inhibition of HIV replication by a CD4-reactive Fab of an IgM clone isolated from a healthy HIV-seronegative individual

European Journal of Immunology

Volumn 40, Issue 5, 2010, Pages 1504-1509

  Hamatake, Makiko ^a   Komano, Jun ^a   Urano, Emiko ^a   Maeda, Fumiko ^b   Nagatsuka, Yasuko ^c   Takekoshi, Masataka ^b  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Autoimmunity; CD4 reactive Ab; IgM; Inhibition of HIV replication

Indexed keywords

CD4 ANTIGEN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN M;

ANTIGEN PURIFICATION; ARTICLE; CONTROLLED STUDY; GENE ISOLATION; GENETIC ANALYSIS; HUMAN; HUMAN EXPERIMENT; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; VIRUS REPLICATION; VIRUS STRAIN;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, CD4; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; CLONE CELLS; HERPESVIRUS 4, HUMAN; HIV SERONEGATIVITY; HIV-1; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN M; VIRUS REPLICATION;

EID: 77951702233     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939479     Document Type: Article

References (32)

1. Henriksson, G., Manthorpe, R. and Bredberg, A., Antibodies to CD4 in primary Sjogren's syndrome. Rheumatology (Oxford) 2000. 39: 142-147. (Pubitemid 30139346)
2. Lenert, P., Lenert, G. and Senecal, J. L., CD4-reactive antibodies in systemic lupus erythematosus. Hum. Immunol. 1996. 49: 38-48.
3. Lopalco, L., Magnani, Z., Confetti, C., Brianza, M., Saracco, A., Ferraris, G., Lillo, F. et al., Anti-CD4 antibodies in exposed seronegative adults and in newborns of HIV type 1-seropositive mothers: a follow-up study. AIDS Res. Hum. Retroviruses 1999. 15: 1079-1085.
4. Herzog, C., Walker, C., Muller, W., Rieber, P., Reiter, C., Riethmuller, G., Wassmer, P. et al., Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells. J. Autoimmun. 1989. 2: 627-642.
5. Rieber, E. P., Federle, C., Reiter, C., Krauss, S., Gurtler, L., Eberle, J., Deinhardt, F. and Riethmuller, G., The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis. Proc. Natl. Acad. Sci. USA 1992. 89: 10792-10796.
6. Bentley, D. L. and Rabbits, T. H., Human immunoglobulin variable region genes - DNA sequences of two V kappa genes and a pseudogene. Nature 1980. 288: 730-733.
7. Moir, S., Lapointe, R., Malaspina, A., Ostrowski, M., Cole, C. E., Chun, T. W., Adelsberger, J. et al., CD40-Mediated induction of CD4 and CXCR4 on B lymphocytes correlates with restricted susceptibility to human immunodeficiency virus type 1 infection: potential role of B lymphocytes as a viral reservoir. J. Virol. 1999. 73: 7972-7980. (Pubitemid 29441655)
8. Kuritzkes, D. R., Jacobson, J., Powderly, W. G., Godofsky, E., DeJesus, E., Haas, F., Reimann, K. A. et al., Antiretroviral activity of the anti-CD4 monoclonal antibody TNX-355 in patients infected with HIV type 1. J. Infect. Dis. 2004. 189: 286-291.
9. Burastero, S. E., Gaffi, D., Lopalco, L., Tambussi, G., Borgonovo, B., De Santis, C., Abecasis, C. et al., Autoantibodies to CD4 in HIV type 1-exposed seronegative individuals. AIDS Res. Hum. Retroviruses 1996. 12: 273-280.
10. Boon, L., Holland, B., Gordon, W., Liu, P., Shiau, F., Shanahan, W., Reimann, K. A. and Fung, M., Development of anti-CD4 MAb hu5A8 for treatment of HIV-1 infection: preclinical assessment in non-human primates. Toxicology 2002. 172: 191-203. (Pubitemid 34219385)
11. Shearer, M. H., Timanus, D. K., Benton, P. A., Lee, D. R. and Kennedy, R. C., Cross-clade inhibition of human immunodeficiency virus type 1 primary isolates by monoclonal anti-CD4. J. Infect. Dis. 1998. 177: 1727-1729.
12. Hurez, V., Kaveri, S. V., Mouhoub, A., Dietrich, G., Mani, J. C., Klatzmann, D. and Kazatchkine, M. D., Anti-CD4 activity of normal human immunoglobulin G for therapeutic use. (Intravenous immunoglobulin, IVIg). Ther. Immunol. 1994. 1: 269-277.
13. Bomsel, M., Pastori, C., Tudor, D., Alberti, C., Garcia, S., Ferrari, D., Lazzarin, A. and Lopalco, L., Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells. AIDS 2007. 21: 13-22. (Pubitemid 44912532)
14. Sugden, B. and Mark, W., Clonal transformation of adult human leukocytes by Epstein-Barr virus. J. Virol. 1977. 23: 503-508. (Pubitemid 8172767)
15. Takekoshi, M., Maeda, F., Tachibana, H., Inoko, H., Kato, S., Takakura, I., Kenjyo, T. et al., Human monoclonal anti-HCMV neutralizing antibody from phage display libraries. J. Virol. Methods 1998. 74: 89-98. (Pubitemid 28386807)
16. Takekoshi, M., Maeda, F., Nagatsuka, Y., Aotsuka, S., Ono, Y. and Ihara, S., Cloning and expression of human anti-tumor necrosis factor-alpha monoclonal antibodies from Epstein-Barr virus transformed oligoclonal libraries. J. Biochem. 2001. 130: 299-303. (Pubitemid 32785879)
17. Matsuda, F., Ishii, K., Bourvagnet, P., Kuma, K., Hayashida, H., Miyata, T. and Honjo, T., The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus. J. Exp. Med. 1998. 188: 2151-2162.
18. Huber, C., Schable, K. F., Huber, E., Klein, R., Meindl, A., Thiebe, R., Lamm, R. and Zachau, H. G., The V kappa genes of the L regions and the repertoire of V kappa gene sequences in the human germ line. Eur. J. Immunol. 1993. 23: 2868-2875.
19. Pech, M. and Zachau, H. G., Immunoglobulin genes of different subgroups are interdigitated within the VK locus. Nucleic Acids Res. 1984. 12: 9229-9236.
20. Healey, D., Dianda, L., Moore, J. P., McDougal, J. S., Moore, M. J., Estess, P., Buck, D. et al., Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding. J. Exp. Med. 1990. 172: 1233-1242.
21. Peterson, A. and Seed, B., Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell 1988. 54: 65-72.
22. Benkirane, M., Hirn, M., Carriere, D. and Devaux, C., Functional epitope analysis of the human CD4 molecule: antibodies that inhibit human immunodeficiency virus type 1 gene expression bind to the immunoglobulin CDR3-like region of CD4. J. Virol. 1995. 69: 6898-6903.
23. Sattentau, Q. J., Dalgleish, A. G., Weiss, R. A. and Beverley, P. C., Epitopes of the CD4 antigen and HIV infection. Science 1986. 234: 1120-1123.
24. Pal, R., Nair, B. C., Hoke, G. M., Sarngadharan, M. G. and Edidin, M., Lateral diffusion of CD4 on the surface of a human neoplastic T-cell line probed with a fluorescent derivative of the envelope glycoprotein (gp120) of human immunodeficiency virus type 1 (HIV-1). J. Cell. Physiol.1991. 147: 326-332.
25. Finnegan, C. M., Rawat, S. S., Cho, E. H., Guiffre, D. L., Lockett, S., MerrillJr., A. H. and Blumenthal, R., Sphingomyelinase restricts the lateral diffusion of CD4 and inhibits human immunodeficiency virus fusion. J. Virol. 2007. 81: 5294-5304. (Pubitemid 46744438)
26. Rawat, S. S., Zimmerman, C., Johnson, B. T., Cho, E., Lockett, S. J., Blumenthal, R. and Puri, A., Restricted lateral mobility of plasma membrane CD4 impairs HIV-1 envelope glycoprotein mediated fusion. Mol. Membr. Biol. 2008. 25: 83-94.
27. Xavier, R., Brennan, T., Li, Q., McCormack, C. and Seed, B., Membrane compartmentation is required for efficient T cell activation. Immunity 1998. 8: 723-732. (Pubitemid 28294519)
28. Millan, J., Cerny, J., Horejsi, V. and Alonso, M. A., CD4 segregates into specific detergent-resistant T-cell membrane microdomains. Tissue Antigens 1999. 53: 33-40. (Pubitemid 29084172)
29. Nguyen, D. H., Giri, B., Collins, G. and Taub, D. D., Dynamic reorganization of chemokine receptors, cholesterol, lipid rafts, and adhesion molecules to sites of CD4 engagement. Exp. Cell. Res. 2005. 304: 559-569.
30. Maeda, F., Nagatsuka, Y., Ihara, S., Aotsuka, S., Ono, Y., Inoko, H. and Takekoshi, M., Bacterial expression of a human recombinant monoclonal antibody fab fragment against hepatitis B surface antigen. J. Med. Virol. 1999. 58: 338-345.
31. Shimizu, S., Urano, E., Futahashi, Y., Miyauchi, K., Isogai, M., Matsuda, Z., Nohtomi, K. et al., Inhibiting lentiviral replication by HEXIM1, a cellular negative regulator of the CDK9/cyclin T complex. AIDS 2007. 21: 575-582. (Pubitemid 46303650)
32. Nagatsuka, Y., Hara-Yokoyama, M., Kasama, T., Takekoshi,M., Maeda, F., Ihara, S., Fujiwara, S. et al., Carbohydrate-dependent signaling from the phosphatidylglucoside-based microdomain induces granulocytic differentiation of HL60 cells. Proc. Natl. Acad. Sci. USA 2003. 100: 7454-7459.